Introduction
Granulocytes, key effector cells in host defenses against microbial infection, destroy invading microorganisms by two principal mechanisms. One of these depends on production of reactive damage or kill ingested microbes (1) (2) (3) .
In addition to such oxidative and peroxidative microbicidal mechanisms, granulocytes are equipped with antimicrobial mechanisms that can operate independently of ROI (3) (4) (5) . Thus, neutrophils obtained from patients with chronic granulomatous disease (6) (7) (8) (9) or normal neutrophils tested under anaerobic conditions (10) (11) (12) retain substantial efficacy against certain bacteria and fungi, even though their ability to generate reactive oxygen intermediates is precluded by disease or by design.
We recently described the biochemical composition and antimicrobial properties of a family of six structurally-related peptides purified from rabbit granulocytes (13, 14) . The peptides were small (32-34 amino acids/molecule), uniformly rich in cysteine (6 residues/molecule), and variably rich in arginine (4-10 residues/molecule) (14) . In vitro, the peptides displayed a range ofantimicrobial activities against bacteria (13) , fungi (15), and certain enveloped viruses (16) .
Because such natural peptide antibiotics might contribute significantly to ROI-independent granulocyte-mediated defenses against infection, we examined human neutrophilic granulocytes (polymorphonucleated neutrophilic leukocytes; PMN) for the presence of analogous molecules. Based on our earlier studies with rabbit granulocytes, we specifically sought small (molecular weight < 4,000), cysteine-rich peptides with activity against herpes simplex virus, type I (HSV-1) in vitro. We herein describe the purification and antimicrobial properties of three such peptides, not previously known to exist in human PMN. The primary structures of these peptides and their homology to the previously-characterized low molecular weight antibiotic peptides of rabbit granulocytes (14) are described in a companion paper ( 17) .
Methods

Purification of human neutrophil peptides (HNP). With approval from
the University of California at Los Angeles Human Subjects Protection Committee, human neutrophils were obtained in single donor leukopheresis packs from a commercial supplier (Hemacare, Van Nuys, CA)
1. Abbreviations used in this paper: AB, antibody buffer; AU-PAGE, acid urea polyacrylamide gel electrophoresis; BPI, bactericidal/permeability-increasing protein; CLCP, chymotrypsin-like cationic proteins; GE, granulocyte extracts; HNP, human neutrophil peptides; HPLC, high performance liquid chromatography; HSV-1, herpes simplex virus, type 1; LPS, lipopolysaccharide; PFU, plaque-forming units; ROI, reactive oxygen intermediates; RP-HPLC, reverse-phase high performance liquid chromatography; TBS, tris-buffered saline.
and were processed within 2 h of harvest. The cells were twice washed of platelets by low speed centrifugation (200 g for 10 min) and resuspension in Dulbecco's phosphate-buffered saline at 4VC. Contaminating erythrocytes were removed by a 45-s cold hypotonic lysis followed by low speed centrifugation. This left a pellet containing 1-3 X 1010 leukocytes, >90% ofwhich were neutrophils, with the remainder consisting mostly oflymphocytes and monocytes. Over 90% ofthe cells were viable by trypan blue exclusion.
The leukocytes were resuspended in 30 ml of 0.34 M sucrose (pH 7.4) and homogenized in a glass teflon pestle homogenizer (Thomas Scientific, Philadelphia, PA) until most cells appeared broken under phase-contrast microscopy. The cell debris and unbroken cells were removed by another low speed centrifugation, 200 g for 10 min, leaving a granule-rich supernatant. The residual cell pellet was subjected to three more cycles of homogenization and centrifugation in 0.34 M sucrose to yield additional granule-rich supernatants. The supernatants were combined and centrifuged at 27,000 g for 30 min at 40C. The resulting pellets were pooled and extracted overnight in 100 ml of 10% acetic acid at 4VC. This extract was cleared at 27,000 g for 30 min and concentrated to -10 ml in a vacuum centrifuge (Speed-Vac; Savant Instruments, Inc., Hicksville, NY).
The steps involved in purifying the defensins, HNP-1, HNP-2, and HNP-3, are summarized in Scheme I and described below. HNP 1-3 denotes a mixture of HNP-1, HNP-2, and HNP-3, as shown in Scheme I, step 3. When used for antimicrobial assays, HNP 1-3 was purified further by reverse-phase high performance liquid chromatography (RP-HPLC) under conditions resulting in the copurification ofits components (see below).
Antibacterial assays. The bactericidal activity of human neutrophil peptides was tested against Staphylococcus aureus 502A, Pseudomonas aeruginosa PAO579, and Escherichia coli ATCC 29648. The organisms were maintained on trypticase soy agar plates, and organisms from a single colony were inoculated into 50 ml of trypticase soy broth (Difco Laboratories, Inc., Detroit, MI) and cultured overnight at 37°C. initially detected and their purification was followed by the marked protection they afforded from virally-induced cytopathic effects (data not shown).
The second assay was quantitative, and measured the direct neutralization of HSV-I by the peptides. Various concentrations of HPLCpurified peptide in 180 Ml of phosphate-buffered saline solution (PBS) were mixed with 20 Ml of titered HSV-I preparations (-4 X 106 PFU/ ml in Eagle's minimal essential medium containing 2% vol/vol fetal bovine serum and antibiotics) and incubated for up to 4 h at 37°C. Control mixtures containing only HSV-I and dilute acetic acid (the vehicle for HNP) in PBS were incubated in parallel at 37°C. At intervals, aliquots of the mixtures were serially diluted and viral PFU were titered in triplicate on Vero cell monolayers by standard techniques. In four representative experiments, the mean coefficient of variation (standard deviation/mean) of this assay procedure was 20.9%.
Immunoperoxidase staining. HNP 1-3 was conjugated to ovalbumin (Sigma Chemical Co., St. Louis, MO) by glutaraldehyde (18), mixed with complete Freund's adjuvant (Difco Laboratories, Inc.), and used to immunize rabbits. Sera were fractionated on DEAE cellulose to provide an IgG fraction used for subsequent staining. Preimmune serum, similarly fractionated, served as the control. Mixed peripheral blood leukocytes were prepared by sedimenting 10 ml of heparinized venous blood that had been mixed with 5 ml of 3% dextran in normal saline. The cells were washed with PBS and were deposited on glass slides with a cytocentrifuge (Shandon Southern Instruments, Inc., Sewickley, PA). Slides were air-dried and then fixed for 10 min in PBS containing 10% formalin, and washed with tris-buffered saline (TBS; 20 mM tris, pH 7.5, 500 mM NaCI). To inactivate endogenous peroxidase activity, the slides were treated with 0.1 M periodic acid for 5 min, rinsed with distilled water, and treated with 0.02% sodium borohydride for 2 min (19) Sections were cut on a Reichert ultracut E. The frozen thin section techniques described by Tokuyasu (21) were used with the modifications for the use of colloidal gold described by Griffiths et al. (22) . The primary antibody was used at a 1:4,000 dilution and immunogold probe, Protein A-5, from Janssen Pharmaceutica Beerse, Belgium was used at a 1:50 dilution. The control for these experiments was nonimmune, purified rabbit IgG or buffer in place of the primary antiserum.
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Volume (ml) Figure 3 . Chromatographic resolution of HNP-l and HNP-2. The mixture of HNP-1 and HNP-2 obtained by ion exchange HPLC was desalted on a Vydac C18 column, Iyophilized, resuspended in 1% acetic acid, and applied to a 137 cm X 3.8 cm column containing Biogel Pl 0. The two peptides were largely resolved by this procedure, and the overlap regions of the effluent were purified by recycling them through the same column.
Results
Peptide purification. Our initial fractionation ofthe concentrated granule extract was accomplished by gel permeation chromatography on a P-10 Biogel column (Bio-Rad Laboratories). Three peptides satisfying our initial search criteria coeluted (Fig. 1 HNP-3, least cathodal. Separation of HNP-3 from HNP-1 and HNP-2 was accomplished by high performance liquid ion exchange chromatography on a carboxymethyl silica column (Biosil TSK-CM; Bio-Rad Laboratories) in 50 mM sodium phosphate/10% acetonitrile, pH 7.0, eluted with a sodium chloride gradient (Fig. 1 ). This was followed by desalting and purification by RP-HPLC over a C-18 alkyl silica column (Vydac; Rainin Instrument Co., Inc., Woburn, MA) in 0.1% trifluoroacetic acid, with elution by an acetonitrile gradient (Fig. 2,  inset) . HNP-I was separated from HNP-2 by recycling the mixture on a 150-cm-long Biogel P-10/I% acetic acid gel permeation system, followed by RP-HPLC as before (Fig. 3) . The fractionation was monitored and the purity ofeach peptide was assessed by AU-PAGE and sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) (Figs. 4 and 5) . The overall purification procedure is summarized in Scheme I.
Antibacterial activity. The effects of exposing S. aureus 502A to HNP 1-3 are shown in Table I . Note that whereas the bacteria were unaffected by the defensins in 10 mM phosphate buffer, addition of either 5 mM glucose or 1% nutrient (trypticase soy) broth sensitized the bacteria to the peptides. In other experiments we observed that 0.05 mM glucose was as effective as 5 mM glucose in sensitizing S. aureus exposed to HNP 1-3 for 2 h (data not shown). Neither 5 mM pyruvate nor a mixture of six amino acids replaced glucose or trypticase soy broth in sensitizing the staphylococci to HNP 1-3.
The susceptibility of two gram-negative bacteria to HNP 1-3 is shown in Table II . Consonant with the observations on S. aureus, neither P. aeruginosa nor E. coli was killed after exposure to 50 Aig/ml of HNP 1-3 in 10 mM phosphate buffer, and both were susceptible when the incubation mixture contained 1% trypticase soy broth. In contrast to the experiments with S. aureus, addition of glucose had little or no effect in inducing sensitivity to the peptides.
Antifungal activity. We tested the activity of HNP 1-3 against C. neoformans C-384. Unlike the aforementioned bacteria, this organism was exquisitely susceptible to HNP 1-3 in nutrientfree buffer. Fig. 6 shows that killing was extensive and timedependent, with a reduction of >3 logo CFU/ml, relative to control, after 4 h of incubation. Colony counts of the controls remained essentially unaltered during the 4-h incubation period. Antiviral effects. The direct inactivation of HSV-1 by HNP 1-3 is illustrated in Fig. 7 , a single, but representative, experiment. Note that the initial rapid fall in viral PFU/ml was followed by a more gradual decline that continued for the duration of the experiment (4 h).
Antimicrobial effects of individual purified defensins. The antimicrobial activity of the individual purified defensins, HNP-1, HNP-2, and HNP-3, was compared with that of the mixture HNP 1-3, as shown in Table III . HNP-l and HNP-2 were as active as HNP 1-3. HNP-3 was less microbicidal than the other Immunocytochemistry. Fig. 8 shows normal human PMNs that have been stained by an immunoperoxidase procedure with antibody to HNP 1-3. Note that the reaction product is cytoplasmic and granular, suggesting that the HNPs are localized to the cell's granules. Neither eosinophils nor lymphocytes contained reaction product. Controls performed with preimmune serum or without antiserum showed no peroxidase staining. Fig. 9 shows the localization of HNP 1-3 in a transmission electron micrograph of a frozen thin section of a human PMN. Leukocytes incubated with antiserum to HNP 1-3 and protein A-gold 5 showed labeling in the azurophil granules and not in the smaller specific granules. In this type ofpreparation the large azurophil granules appear electron-lucent, probably because their buffer, and are derived from INCUBATION TIME (hours) nineseparateexperiments.
contents have been partially solubilized. The tendency of azurophil granules to be easily extracted has been pointed out in earlier electron microscopic studies (23, 24) . No labeling was seen when normal rabbit serum or buffer replaced the primary antibody.
Discussion
The ability of PMN to kill microorganisms is a key component of host defenses against infection. The microbicidal properties of PMN arise from two fundamentally distinct mechanisms. Best understood are the mechanisms linked to production of ROI by PMN (reviewed in 2, 3, 25). The production of molecules such as OH', H202, HOCl, and reactive chloramines equips the PMN with potent, nonspecific antimicrobial effectors that can act against diverse potential pathogens. Vero cells after suitable dilu-TIME (hours) tion.
Human Neutrophil Defensins 1431 Data are shown in logl0 units. The input column shows the absolute concentration of bacteria or fungi in CFU/ml or of HSV-I in PFU/ml at the outset of the incubation. The remaining data show the decrease in CFU/ml, relative to the input, after a 2-h incubation of fungi or bacteria with 50 jg/ml of a mixture of the three defensins (HNP 1-3) or with 50 tg/ml of the individual peptides. C. neoformans was incubated in nutrient-free 10 mM phosphate buffer, pH 7.4, whereas bacteria were incubated in that buffer supplemented with 1% vol/vol trypticase soy broth. A minus sign indicates that the CFU/ml at 2 h was higher than the input (i.e., that growth had occurred). Experiments with HSV-I were conducted by exposing rium (8, 9) , Neisseria gonorrhoeae (7) , and Candida parapsilosis and C. pseudotropicalis (6) with considerable efficacy in vitro.
Stringently anaerobic conditions preclude ROI production by PMN. Yet, under anaerobic conditions, normal human PMN retain substantial activity against many bacteria (10) (11) (12) (29) . Zeya and Spitznagel (30, 31) greatly refined these observations, demonstrating that "phagocytin" contained a family of small proteins, "Iysosomal cationic proteins," that were rich in arginine and cysteine, and displayed specificity in their bactericidal spectrum. We recently purified these rabbit PMN "Iysosomal cationic peptides" to homogeneity, and established their amino acid sequences (14) . The peptides are composed of 32-34 amino acid residues/molecule. Although variably arginine-rich, all six peptides contain a strictly conserved, nonconsecutive framework composed of 11 amino acid residues. Some of the rabbit granulocyte peptides have been crystallized (32) and are being analyzed by x-ray crystallography. The antimicrobial spectrum of the purified rabbit granulocyte peptides includes aerobic bacteria ( 13) , fungi ( 15, 33), and certain enveloped viruses (16) , such as HSV- 1. Human PMN contain a group ofchymotrypsin-like cationic proteins (CLCP) that exhibit microbicidal properties against gram-positive and gram-negative bacteria (34-36) and fungi (37) . Their microbicidal effects do not depend on proteolytic activity, for heating abolishes the enzymatic activity of CLCP without decreasing its antimicrobial properties (35) . Another antimicrobial constituent ofgranulocytes, described by Elsbach et al. (38) , is a distinctive cationic (pI > 9.6) protein, that was named for its bactericidal/permeability-increasing properties (BPI). Present in rabbit and human granulocytes, its actions are reportedly specific for certain gram-negative bacteria. Both BPI (50,000-58,000 mol wt) and CLCP (25,000-28,000 mol wt) are considerably larger than the six small rabbit granulocyte cationic peptides (38, 39) , or their human counterparts, the defensins (3,300-3,900 mol wt).
At least two other components of PMN granules, lysozyme (muramidase) and (apo)lactoferrin, may also contribute to microbicidal activity. Lysozyme, discovered by Fleming in 1922, hydrolyses the beta 1-4 linkage between N-acetylglucosamine and N-acetylmuramic acid residues in bacterial cell wall peptidoglycans. Lysozyme can kill a limited spectrum ofgram-positive bacteria (e.g., Micrococcus lysodeikticus and Bacillus megaterium [ I ]) and fungi (e.g., Coccidioides immitis [40] and C. neoformans [41] ) in vitro. Apolactoferrin may kill certain susceptible bacteria directly, e.g., Streptococcus mutans and Vibrio cholerae (42) . In addition, lactoferrin may interact with ROI to facilitate generation of hydroxyl radicals from superoxide and hydrogen peroxide (43, 44) .
Studies with partially purified granule extracts (GE) have also yielded valuable insights into the potential antimicrobial constituents of PMN. Spitznagel and his associates extracted human PMN granules with 0.2 M acetate buffer, pH 4.0, and tested the bactericidal activity of this GE. Using defined outermembrane mutants, Rest et al. (44, 45) found that S. typhimurium LT2 and other Enterobacteriaceae became increasingly susceptible to human GE as the carbohydrate content of their lipopolysaccharide (LPS) decreased. Bacteria grown with aeration to log phase were killed by GE from 10 to 15 times more effectively than bacteria grown to stationary phase under static conditions. Bactericidal activity of human GE against Enterobacteriaceae was time, temperature, pH, and concentration-dependent (46 (49) .
The three cysteine-rich antimicrobial peptides (defensins) described in this report are, by amino acid sequence determination, homologous to the family of six low molecular weight cationic peptides of rabbit PMN (14) . Specifically, they are composed of 29 (HNP-2) or 30 (HNP-1 and HNP-3) amino acid residues and retain all of the 11 "framework" residues common to the rabbit peptides ( 17) . Additional studies are required before we can assess the overall contributions of HNP-1, HNP-2, and HNP-3 to PMN-mediated human host defenses. However, the presence of antibiotic peptides in the cytoplasmic granules of PMN, cells whose primary responsibility is in defense against microbial infection, is unlikely to be coincidental. Our finding that the human PMN's defensins are contained in large, myeloperoxidase-containing azurophil granules is consistent with earlier studies defining the localization ofthe low molecular weight cationic peptides of rabbit PMN (50). The defensins and their homologs in leukocytes of other species are likely to endow PMNs with the ability to kill a wide variety of potential pathogens.
